Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor

Clinical trial NCT04545632 · COMPLETED

Trial details

NCT number: NCT04545632
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer NSCLC Prostate Cancer Head and Neck Cancer Gastric Cancer Esophageal Cancer Ovarian Cancer

Start date: 2020-06-10
Primary completion: 2021-02-26
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.